Scarica l'app Stockscreener
17.58
2.21%
0.38
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$17.20
Aprire:
$18.14
Volume 24 ore:
2.32M
Relative Volume:
2.39
Capitalizzazione di mercato:
$1.37B
Reddito:
$1.64B
Utile/perdita netta:
$-495.80M
Rapporto P/E:
-2.7452
EPS:
-6.404
Flusso di cassa netto:
$-45.25M
1 W Prestazione:
+0.40%
1M Prestazione:
+24.59%
6M Prestazione:
+34.71%
1 anno Prestazione:
+47.61%
Intervallo 1D:
$17.50
$18.30
Intervallo di 1 settimana:
$17.09
$18.30
Portata 52W:
$8.70
$18.30
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Nome
Integra Lifesciences Holdings Corp
Settore
Industria
Telefono
(609) 275-0500
Indirizzo
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
17.58 | 1.37B | 1.64B | -495.80M | -45.25M | -6.404 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Downgrade | Argus | Buy → Hold |
| 2025-03-31 | Aggiornamento | Argus | Hold → Buy |
| 2024-12-02 | Iniziato | Morgan Stanley | Underweight |
| 2024-10-07 | Aggiornamento | BTIG Research | Sell → Neutral |
| 2024-07-30 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-07-30 | Downgrade | Citigroup | Neutral → Sell |
| 2024-05-07 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-12-05 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Iniziato | CL King | Buy |
| 2023-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-08 | Downgrade | Argus | Buy → Hold |
| 2023-05-24 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Downgrade | Citigroup | Neutral → Sell |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-25 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2021-12-17 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Iniziato | Citigroup | Neutral |
| 2020-04-03 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Iniziato | SunTrust | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-08-07 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-07-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Iniziato | UBS | Buy |
Mostra tutto
Integra Lifesciences Holdings Corp Borsa (IART) Ultime notizie
Integra LifeSciences Opens with 5.47% Gain, Marking Significant Gap Up - MarketsMojo
Integra LifeSciences (IART) Upgraded to Buy with Positive Outloo - GuruFocus
Argus upgrades Integra LifeSciences stock rating on turnaround - Investing.com
Argus upgrades Integra LifeSciences stock rating on turnaround By Investing.com - Investing.com Canada
Why is Integra LifeSciences stock gaining today? By Investing.com - Investing.com South Africa
Integra Lifesciences Holdings Corp - TradingKey
Integra Lifesciences Holdings Corp (IART) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Integra Lifesciences Holdings Corp (IART) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Integra Lifesciences Holdings Corp (IART) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Integra Lifesciences Holdings Corp (IART) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Integra Lifesciences Holdings Corp (IART) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Integra Lifesciences Holdings Corp (IART) Valuation: PE, PB & Fair Value Analysis - TradingKey
Integra Lifesciences Holdings Corp (IART) Institutional Confidence - TradingKey
Integra Lifesciences Holdings Corp (IART) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Integra LifeSciences Hits New 52-Week High at $18.18 - MarketsMojo
Integra LifeSciences Holdings Corporation (IART) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference - Yahoo Finance
Integra LifeSciences Hits New 52-Week High at $17.79 - Markets Mojo
Integra LifeSciences Hits New 52-Week High at $18.02 - MarketsMojo
Integra LifeSciences stock hits 52-week high at 17.84 USD - Investing.com
Integra LifeSciences (IART) EPS Beat and Conference Push: What Does It Reveal About Management’s Conviction? - Yahoo Finance
3 Reasons to Avoid IART and 1 Stock to Buy Instead - Yahoo Finance
Why Is Integra (IART) Up 15% Since Last Earnings Report? - Yahoo Finance
Integra (IART) EVP awarded RSUs and stock options in new grant - Stock Titan
Integra (IART) CEO receives new RSU and stock option grants - Stock Titan
Integra LifeSciences Hits New 52-Week High at $16.70 - Markets Mojo
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Integra LifeSciences (IART) Investors of Pending Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm's Attorneys - TMX Newsfile
Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewswire
CFO Lea Knight to speak June 3 at Jefferies healthcare forum - Stock Titan
Integra LifeSciences Hits New 52-Week High at $16.62 - Markets Mojo
Integra LifeSciences Hits Day High with 8.36% Surge in Stock Price - MarketsMojo
Integra LifeSciences Holdings Corporation (IART) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Why Integra LifeSciences (IART) Stock Is Trading Up Today - Yahoo Finance
Is It Too Late to Buy Integra Lifesciences Holdings Corp (IART) After 8.4% Rally? GF Value Says Undervalued - GuruFocus
IART Upgraded by Citigroup -- Price Target Raised to $16.00 - GuruFocus
Integra LifeSciences stock hits 52-week high at $16.49 - Investing.com
Zacks.com featured highlights include DaVita, Integra LifeSciences, Braskem and LyondellBasell - Yahoo Finance
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It - Benzinga
Integra LifeSciences (IART) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
A Look At Integra LifeSciences Holdings (IART) Valuation After Recent Share Price Momentum - Yahoo Finance
Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears - Yahoo Finance
Paradigm Capital holds 4.01M shares of Integra LifeSciences (IART) - Stock Titan
The Top 5 Analyst Questions From Integra LifeSciences’s Q1 Earnings Call - Yahoo Finance
Integra LifeSciences (IART) Is Up 6.4% After Essig Returns As CEO With Reaffirmed 2026 Guidance - Yahoo Finance
Integra LifeSciences Announces Leadership Transition - Orthopedics This Week
Integra (IART) director receives 24,338-share stock awards - Stock Titan
Integra (IART) director gets 17,700 RSUs; 882 shares withheld for taxes - Stock Titan
Integra LifeSciences (IART) director receives 17,700 RSU grant - Stock Titan
Integra LifeSciences (IART) director Jeffrey Graves receives 17,700 RSU award - Stock Titan
Renee Wonlai Lo awarded 17,700 RSUs at Integra LifeSciences (IART) - Stock Titan
Integra Lifesciences Holdings Corp Azioni (IART) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Integra Lifesciences Holdings Corp Azioni (IART) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '26 |
Option Exercise |
0.00 |
1,216 |
0 |
23,152 |
| Poul Mojdeh | President & CEO |
Jan 06 '26 |
Option Exercise |
0.00 |
1,390 |
0 |
1,390 |
| GRAVES JEFFREY A | Director |
Nov 05 '25 |
Buy |
11.35 |
9,000 |
102,150 |
41,086 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):